{"text": ["Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis\u00ae (carfilzomib) Over Velcade\u00ae (bortezomib) In Patients With Relapsed Multiple Myeloma"], "created_at": "Sun, 01 Mar 2015 08:00:00 GMT"}
